Status: Automated market-move research draft
MAXHEALTH • NSE • F&O Stock
MAX HEALTHCARE INS LTD traded at ₹992.80, -2.09% versus the previous close of ₹1,014.00. Latest market data: 28 Sep 2026 • 09:25 AM IST.
- The stock is -2.09% at ₹992.80.
- Likely reason: technical cooling and sector-linked profit-taking
- Approximate traded value is ₹20.61 crore.
- It is -18.75% from its 52-week high and +9.94% from its 52-week low.
- The stock is being compared with Nifty Pharma alongside the Nifty 50.
MAX HEALTHCARE INS LTD Share Price Today – Market Snapshot
Why Is MAX HEALTHCARE INS LTD Share Price Falling Today?
Max Healthcare Institute Ltd (MAXHEALTH) is trading lower today, down 2.09% at ₹992.80 compared to its previous close of ₹1014.00. The stock opened at ₹1009.70 and has moved within a tight intraday range, hitting a high of ₹1010.80 and a low of ₹992.50. Trading volumes remain subdued, with current volume tracking significantly lower compared to its 5-day and 20-day averages, indicating measured selling pressure rather than heavy liquidation.
The broader market and healthcare segment are also facing downward pressure, though the stock's pullback aligns with a broader correction in its recent price trajectory. The Nifty index declined by 1.01% while the Nifty Pharma sector benchmark moved down by 0.46%. MAXHEALTH has experienced a sharper near-term pullback, registering a 5-day return loss of 6.95% and a 20-day decline of 4.76%, reflecting persistent short-term profit-taking after lingering near its 52-week highs earlier.
While no single immediate catalyst directly triggered today's downward drift, the stock's recent price action coincides with ongoing operational expansions, including the recent inauguration of a new 400-bed tower at Max Smart Super Speciality Hospital, Saket, by Union Home Minister Amit Shah, and the continued funding infusion into Kalinga Hospital Ltd. These developments underscore long-term capacity growth, though immediate sentiment remains influenced by broader market consolidation and technical cooling following prior gains.
low confidence
- Stock down 2.09% amid lower-than-average trading volumes
- Negative 5-day return of 6.95% indicating ongoing short-term consolidation
- Broader market weakness led by a 1.01% drop in the Nifty index
Performance Context
Cash-Market Activity
| Today’s Volume | 207,607 |
|---|---|
| 5-Day Avg. Volume | 1,387,606 |
| 20-Day Avg. Volume | 1,743,887 |
| Volume vs 20-Day Avg. | 0.12x |
| Delivery Quantity | 1,090,852 |
| Delivery % | 57.39% |
| Number of Trades | 39,404 |
Derivative-Market Activity
| Near-Month Futures | ₹1,013.80 |
|---|---|
| Cash Reference | ₹1,014.00 |
| Premium / Discount | ₹-0.20 (-0.02%) |
| Change in Premium | ₹-2.70 |
| Futures Volume | 9,103 |
| Volume vs Previous Session | 1.04x |
| Open Interest | 2,694,825 |
| OI vs Previous Session | 0.46x |
Ownership & Transaction Activity
Promoter Pledge / Encumbrance
Plot C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 Symbol: MAXHEALTH Listing Department, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 543220 Sub.: Disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Dear Sir / Madam, Pursuant to regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, I, Abhay Soi, Promoter of Max Healthcare Institute Limited (“ Company”) hereby declare that I and Mr. Aditya Soi (a member of promoter group) have not made any encumbrance on the shares of Company, directly or indirectly, during the financial year 2024- 25. Kindly take this intimation on your record. Thanking you Abhay Soi CC: Chairman Audit Committee Max Healthcare Institute Limited 401, 4th Floor, Man Excellenza, S. V. Road, Vile Parle (West), Mumbai, Maharashtra – 400 056
Source: NSE corporate filing
Recent Ownership / Shareholding Disclosure
- Promoter Abhay Soi and promoter group member Aditya Soi declared no encumbrance on company shares under SEBI Regulation 31(4).
- Institutional shareholding remains robust, with Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) holding significant stakes in the company.
Source: NSE corporate disclosure. Only factual ownership/shareholding details extracted from the filing are shown.
WittyTrades Data Insight
Price Position: The stock is near the lower end of the day’s trading range.
Move From Open: -1.67%.
Intraday Range: 1.80% of the previous close.
5-Day Performance: -6.95%; 20-Day Performance: -4.76%.
Latest Company Developments
Relative Performance
| MAX HEALTHCARE INS LTD | -2.09% |
|---|---|
| Nifty 50 | -1.01% |
| Nifty Pharma | -0.46% |
| Vs Nifty 50 | -1.08% |
| Vs Sector | -1.63% |
Technical Context
| Price | ₹992.80 |
|---|---|
| Day High / Low | ₹1,010.80 / ₹992.50 |
| 52-Week High | ₹1,221.90 |
| 52-Week Low | ₹903.00 |
| 5-Day Return | -6.95% |
| 20-Day Return | -4.76% |
What Should Traders and Investors Watch Next?
- Sustainability of support levels around the ₹990 mark and intraday volume pickup
- Execution progress and patient ramp-up timelines for the newly inaugurated 400-bed Saket tower
- Integration milestones and financial impact of the Kalinga Hospital fund infusion
- Derivatives positioning and open interest trends as the near-term monthly expiry approaches
Catalyst note: No single confirmed fundamental trigger explains today's price drop; the move reflects routine technical retracement and broader market sentiment.
Frequently Asked Questions
What is the likely reason for today’s move?
The stock's decline appears driven by mild profit-taking and broader market consolidation following a period of short-term weakness, with no direct negative news event reported today.
Is trading volume elevated?
Today’s volume is 207,607. The latest 20-day average available is 1,743,887, equivalent to about 0.12x of the recent average.
What does the derivatives market show?
The latest official NSE F&O report is summarised in the Derivative-Market Activity box above.
Before acting on this stock
Consult your own investment adviser before acting on any security. If you are interested in stock research or other available research categories, review the WittyTrades subscription plans and research segments.
Market data, exchange filings, company disclosures and reputable business-media reports are collected automatically and summarised for investor context. Material facts are cross-checked where possible; price data may be delayed and a cited development should not be assumed to be the sole cause of a market move unless the evidence supports that conclusion.
Article by: WittyTrades Research Desk
Investments in securities markets are subject to market risks. Read all related documents carefully before investing.
Registration granted by SEBI, membership of a supervisory body and certification from NISM do not guarantee performance of the intermediary or provide any assurance of returns to investors.
This article is intended for informational and educational purposes and should not be treated as personalised investment advice or a recommendation to buy, sell or hold any security.
Market data may be delayed and readers should independently verify current prices and disclosures before taking investment decisions.